300 related articles for article (PubMed ID: 3898762)
1. Pathophysiology of insulin secretion in diabetes mellitus.
Ward WK; Beard JC; Halter JB; Porte D
Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
[TBL] [Abstract][Full Text] [Related]
2. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
[TBL] [Abstract][Full Text] [Related]
3. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.
Ward WK; Beard JC; Halter JB; Pfeifer MA; Porte D
Diabetes Care; 1984; 7(5):491-502. PubMed ID: 6094129
[TBL] [Abstract][Full Text] [Related]
5. Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man.
Hollander PM; Asplin CM; Palmer JP
Diabetes; 1982 Jun; 31(6 Pt 1):489-95. PubMed ID: 6759265
[TBL] [Abstract][Full Text] [Related]
6. Insulin secretion in diabetes mellitus.
Pfeifer MA; Halter JB; Porte D
Am J Med; 1981 Mar; 70(3):579-88. PubMed ID: 7011013
[TBL] [Abstract][Full Text] [Related]
7. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
Greenbaum CJ; Prigeon RL; D'Alessio DA
Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
[TBL] [Abstract][Full Text] [Related]
8. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
Kruszynska YT; Goulas S; Wollen N; McIntyre N
J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
[TBL] [Abstract][Full Text] [Related]
9. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.
Judzewitsch RG; Pfeifer MA; Best JD; Beard JC; Halter JB; Porte D
J Clin Endocrinol Metab; 1982 Aug; 55(2):321-8. PubMed ID: 7045153
[TBL] [Abstract][Full Text] [Related]
10. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM.
Ortiz-Alonso FJ; Herman WH; Zobel DL; Perry TJ; Smith MJ; Halter JB
Diabetes; 1991 Sep; 40(9):1194-202. PubMed ID: 1936624
[TBL] [Abstract][Full Text] [Related]
11. Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus.
Shankar RR; Zhu JS; Baron AD
Metabolism; 1998 May; 47(5):573-7. PubMed ID: 9591749
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus.
Ward WK; Johnston CL; Beard JC; Benedetti TJ; Halter JB; Porte D
Diabetes; 1985 Sep; 34(9):861-9. PubMed ID: 3896896
[TBL] [Abstract][Full Text] [Related]
13. In vivo beta-cell function at the transition to early non-insulin-dependent diabetes mellitus.
Swinburn BA; Gianchandani R; Saad MF; Lillioja S
Metabolism; 1995 Jun; 44(6):757-64. PubMed ID: 7783660
[TBL] [Abstract][Full Text] [Related]
14. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
15. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
Reaven GM
Diabetes Care; 1984; 7 Suppl 1():17-24. PubMed ID: 6376025
[TBL] [Abstract][Full Text] [Related]
16. Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus.
Dimitriadis GD; Pehling GB; Gerich JE
Diabetes; 1985 Jun; 34(6):541-7. PubMed ID: 3891467
[TBL] [Abstract][Full Text] [Related]
17. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
Herman WH; Fajans SS; Smith MJ; Polonsky KS; Bell GI; Halter JB
Diabetes; 1997 Nov; 46(11):1749-54. PubMed ID: 9356021
[TBL] [Abstract][Full Text] [Related]
18. Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice.
Hamada Y; Ikegami H; Ueda H; Kawaguchi Y; Yamato E; Nojima K; Yamada K; Babaya N; Shibata M; Ogihara T
Metabolism; 2001 Nov; 50(11):1282-5. PubMed ID: 11699045
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
[TBL] [Abstract][Full Text] [Related]
20. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
Hamaguchi T; Fukushima H; Uehara M; Wada S; Shirotani T; Kishikawa H; Ichinose K; Yamaguchi K; Shichiri M
Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
